Quetiapine Fumarate Patent Expiration
Quetiapine Fumarate is Used for treating major depressive disorder (MDD) and schizophrenia. It was first introduced by Cheplapharm Arzneimittel Gmbh
Quetiapine Fumarate Patents
Given below is the list of patents protecting Quetiapine Fumarate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Seroquel Xr |
US5948437 (Pediatric) | Pharmaceutical compositions using thiazepine |
Nov 28, 2017
(Expired) | Cheplapharm |
Seroquel Xr | US5948437 | Pharmaceutical compositions using thiazepine |
May 28, 2017
(Expired) | Cheplapharm |
Quetiapine Fumarate's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List